Dissociatives Daily/Weekly/Biweekly/Monthly/Quarterly/Yearly: A Harm Reduction Framework for Dissociative Use AbstractThis serious Harm Reduction article explicitly aims to save lives and reduce harm by providing a comprehensive analysis of dissociative substances anchored around a reference dose of 40 mg memantine. The focus is on offering actionable, honest benchmarks to enable safer decision-making while highlighting the … Continue reading Memantine and NMDA Antagonists: Harm Reduction